10 June 2012

Generics Drive Down Drug Prices In India, TPP Trying To Stop That

Back in March, we wrote about an important development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back

On Techdirt.

No comments: